share_log

HLS Therapeutics Inc: 52109F2 CERTIFICATION OF INTERIM FILINGS CEO EN

SEDAR ·  Nov 7, 2024 12:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more